XML 24 R50.htm IDEA: XBRL DOCUMENT v2.4.0.8
Summarized Amount of Collaboration Recorded in Consolidated Statement of Operations (Detail) (USD $)
In Thousands, unless otherwise specified
 3 Months Ended 6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2014
Jun. 30, 2013
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues $ 11,764 $ 6,674 $ 19,601 $ 10,538
Ziopharm Oncology, Inc.
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 4,341 2,935 7,021 5,009
Synthetic Biologics, Inc.
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 193 1,980 552 2,550
Oragenics, Inc.
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 313 471 1,108 987
Fibrocell Science, Inc.
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 1,331 773 2,641 1,361
Genopaver, LLC
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 491 281 981 281
S & I Ophthalmic, LLC
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 607   1,486  
OvaXon, LLC
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 579   748  
Intrexon Energy Partners, LLC
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 1,835   1,835  
Other Collaborations
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 2,074 234 3,229 350
Upfront and Milestone Payments
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 2,517 2,751 4,399 3,888
Upfront and Milestone Payments | Ziopharm Oncology, Inc.
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 644 644 1,288 1,288
Upfront and Milestone Payments | Synthetic Biologics, Inc.
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 163 1,666 325 1,861
Upfront and Milestone Payments | Oragenics, Inc.
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 261 137 523 274
Upfront and Milestone Payments | Fibrocell Science, Inc.
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 448 158 896 316
Upfront and Milestone Payments | Genopaver, LLC
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 68 68 137 68
Upfront and Milestone Payments | Intrexon Energy Partners, LLC
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 625   625  
Upfront and Milestone Payments | Other Collaborations
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 308 78 605 81
Research And Development Services
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 9,247 3,923 15,202 6,650
Research And Development Services | Ziopharm Oncology, Inc.
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 3,697 2,291 5,733 3,721
Research And Development Services | Synthetic Biologics, Inc.
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 30 314 227 689
Research And Development Services | Oragenics, Inc.
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 52 334 585 713
Research And Development Services | Fibrocell Science, Inc.
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 883 615 1,745 1,045
Research And Development Services | Genopaver, LLC
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 423 213 844 213
Research And Development Services | S & I Ophthalmic, LLC
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 607   1,486  
Research And Development Services | OvaXon, LLC
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 579   748  
Research And Development Services | Intrexon Energy Partners, LLC
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 1,210   1,210  
Research And Development Services | Other Collaborations
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues $ 1,766 $ 156 $ 2,624 $ 269